Chemed (CHE) Income from Continuing Operations: 2009-2024
Historic Income from Continuing Operations for Chemed (CHE) over the last 16 years, with FY2024 value amounting to $302.0 million.
- Chemed's Income from Continuing Operations fell 1522.78% to $64.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $278.8 million, marking a year-over-year decrease of 759.84%. This contributed to the annual value of $302.0 million for FY2024, which is 1082.17% up from last year.
- Per Chemed's latest filing, its Income from Continuing Operations stood at $302.0 million for FY2024, which was up 1082.17% from $272.5 million recorded in FY2023.
- Chemed's 5-year Income from Continuing Operations high stood at $319.5 million for FY2020, and its period low was $249.6 million during FY2022.
- For the 5-year period, Chemed's Income from Continuing Operations averaged around $282.4 million, with its median value being $272.5 million (2023).
- Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 4526.27% in 2020, then crashed by 1593.78% in 2021.
- Chemed's Income from Continuing Operations (Annual) stood at $319.5 million in 2020, then decreased by 15.94% to $268.6 million in 2021, then decreased by 7.05% to $249.6 million in 2022, then rose by 9.17% to $272.5 million in 2023, then grew by 10.82% to $302.0 million in 2024.
- Its last three reported values are $302.0 million in FY2024, $272.5 million for FY2023, and $249.6 million during FY2022.